Improving the Patient-Clinician and Parent-Clinician Partnership in Atopic Dermatitis Management

Seminars in Cutaneous Medicine and Surgery

Volumn 31, Issue 3 SUPPL., 2012, Pages

  Mancini, Anthony J ^a,e   Paller, Amy S ^a,e   Simpson, Eric L ^b   Ellis, Charles N ^c   Eichenfield, Lawrence F ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Atopic dermatitis; Psychiatric comorbidities; Steroid phobia; Treatment adherence

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; PIMECROLIMUS; TACROLIMUS; TRIAMCINOLONE;

AMBULATORY CARE; ANXIETY; ATOPIC DERMATITIS; BATH; CLINICAL EFFECTIVENESS; DOCTOR PATIENT RELATION; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; MEDICAL INFORMATION; PARENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SAFETY; REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; BATHS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; FEMALE; FOOD HYPERSENSITIVITY; HEALTH EDUCATION; HUMANS; INFANT; MALE; PARENTS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PROFESSIONAL-FAMILY RELATIONS;

EID: 84866859723     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2012.07.003     Document Type: Review

References (24)

1. Nolan B.V., Feldman S.R. Dermatologic medication adherence. Dermatol Clin 2009, 27:113-120.
2. Aubert-Wastiaux H., Moret L., Le Rhun A., et al. Topical corticosteroid phobia in atopic dermatitis: A study of its nature, origins and frequency. Br J Dermatol 2011, 165:808-814.
3. Richards H.L., Fortune D.G., O'Sullivan T.M. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999, 41:581-583.
4. Krejci-Manwaring J., Tusa M.G., Carroll C., et al. Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2007, 56:211-216.
5. Scholtz J.R. Management of atopic dermatitis: A preliminary report. Calif Med 1964, 100:103-105.
6. Scholtz J.R. Management of atopic dermatitis. Calif Med 1965, 102:210-216.
7. Chiang C., Eichenfield L.F. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. Pediatr Dermatol 2009, 26:273-278.
8. Gutman A.B., Kligman A.M., Sciacca J. Soak and smear: A standard technique revisited. Arch Dermatol 2005, 141:1556-1559.
9. Niggemann B., Sielaff B., Beyer K. Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clin Exp Allergy 1999, 29:91-96.
10. Sampson H.A., Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984, 74:26-33.
11. Suh L., Coffin S., Leckerman K.H. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. Pediatr Dermatol 2008, 25:528-534.
12. Krakowski A.C., Eichenfield L.F., Dohil M.A. Management of atopic dermatitis in the pediatric population. Pediatrics 2008, 122:812-824.
13. Liu T., Howard R.M., Mancini A.J., et al. Kwashiorkor in the United States: Fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol 2001, 137:630-636.
14. Boyce J.A., Assa'ad A., Burks A.W., et al. Guidelines for the diagnosis and management of food allergy in the United States: Report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010, 126:S1-S58.
15. Burks A.W., Tang M., Sicherer S., et al. ICON: Food allergy. J Allergy Clin Immunol 2012, 129:906-920.
16. Yang L.P., Curran M.P. Spotlight on topical pimecrolimus in pediatric atopic dermatitis. Am J Clin Dermatol 2010, 11:295-298.
17. Ohtsuki M, Ohara H, Santos V: Safety profiles of two large cohort studies of tacrolimus ointment for the treatment of atopic dermatitis: A prospective pediatric longitudinal evaluation study (APPLES) and Japanese long-term safety study (J-LSS). Poster presented at: 22nd World Congress of Dermatology; May 24-29, 2011; Seoul, Korea.
18. Manthripragada A. Topical calcineurin inhibitors and malignancies in pediatric patients: A literature review Presented at: U.S. Food and Drug Administration Pediatric Advisory Committee Meeting, May 16, 2011, Accessed June 12, 2012. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255411.pdf.
19. Chen S.L., Yan J., Wang F.S. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials. J Dermatolog Treat 2010, 21:144-156.
20. Chisolm S.S., Taylor S.L., Balkrishnan R. Written action plans: Potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 2008, 59:677-683.
21. Ntuen E., Taylor S.L., Kinney M., et al. Physicians' perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat 2010, 21:28-33.
22. Fleischer A.B. Written action plans should be comprehensive and evidence-based. J Am Acad Dermatol 2011, 65:1059.
23. Nicol N.H., Ersser S.J. The role of the nurse educator in managing atopic dermatitis. Immunol Allergy Clin North Am 2010, 30:369-383.
24. Moore E., Williams A., Manias E., et al. Nurse-led clinics reduce severity of childhood atopic eczema: A review of the literature. Br J Dermatol 2006, 155:1242-1248.